Source: Biospectrum Asia

KeenEye Technologies: Keen Eye launches AI platform to accelerate clinical trials in digital pathology

The platform is dedicated to organizations conducting clinical trial assays in an environment following GCLP (Good Clinical Laboratory Practices) principles

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Sylvain Berlemont's photo - Founder & CEO of KeenEye Technologies

Founder & CEO

Sylvain Berlemont

CEO Approval Rating

62/100

Read more